Gary Miller - Exactech Insider

Exactech Inc -- USA Stock  

USD 32.2  0.15  0.46%

Co-Founder and Executive VP of RandD

Dr. Gary J. Miller, Ph.D., is Executive Vice President Research and Development of Exactech Inc. He was Vice President, Research and Development from 1986 until 2000 and was a Director from March 1989 through May 2003. Dr. Miller was Associate Professor of Orthopaedic Surgery and Director of Research and Biomechanics at the University of Florida College of Medicine from July 1986 until August 1996
Age: 68  Founder Since 2003      
352 378-2617  www.exac.com
Miller received his B.S.M.E. from the University of Florida, his M.S.M.E. from the Massachusetts Institute of Technology, and his Ph.D. in Mechanical Engineering from the University of Florida . He previously held an Adjunct Associate Professorship in the College of Veterinary Medicine?s Small Animal Surgical Sciences Division and served as an Adjunct Associate Professor in the Department of Aerospace, Mechanics and Engineering Sciences from 1995 until 2010 at UF. He has held a Courtesy Professorship in the Department of Mechanical and Aerospace Engineering, University of Florida since 2011. He was a consultant to the FDA from 1989 to 1992 and has served as a consultant to such companies as Johnson & Johnson Orthopaedics, DowCorning Wright and Orthogenesis.

Gary Miller Latest Insider Activity

Gary Miller over a month ago via Macroaxis 
A Schulman exotic insider transaction detected
Gary Miller over two months ago via Macroaxis 
Exactech exotic insider transaction detected
Gary Miller over three months ago via Macroaxis 
Exactech exotic insider transaction detected

Management Efficiency

The company has return on total asset (ROA) of 4.96 % which means that it generated profit of $4.96 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 0.32 % meaning that it created $0.32 on every $100 dollars invested by stockholders.
The company currently holds 14 M in liabilities with Debt to Equity (D/E) ratio of 5.6 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Exactech Inc has Current Ratio of 4.03 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Entity Summary

Exactech, Inc. develops, manufactures, markets, distributes, and sells orthopedic implant devices, related surgical instrumentation, and biologic services. Exactech Inc (EXAC) is traded on NASDAQ in USA. It is located in FLORIDA, U.S.A and employs 674 people. Exactech is listed under Medical Equipment category by Fama And French industry classification.

Did you try this?

Run Portfolio Anywhere Now
   

Portfolio Anywhere

Track or share privately all of your investments from the convenience of any device
Hide  View All  Next  Launch Portfolio Anywhere
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Exactech Inc to your portfolio

Top Management

Exactech Inc Leadership Team
David Petty, CEO
Betty Petty, President
Richard Smith, Director
Donna Edwards, President
William Locander, Director
R Petty, Chairman
Joel Phillips, CFO
Betty MD, Founder
Andrew Krusen, Director
W Krusen, Director
Bruce Thompson, SVP, MBA
James Binch, Director, MBA
Gary Miller, Founder
Fern Watts, Director
William Petty, Chairman

Stock Performance

Exactech Performance Indicators